Choong Ang Vaccine Laboratory Co., Ltd. announces an Equity Buyback for 100,000 shares.
March 13, 2020 at 11:41 am IST
Share
Choong Ang Vaccine Laboratory Co., Ltd. (KOSDAQ:A072020) announces a share repurchase program. Under the program, the company will repurchase up to 100,000 shares. The purpose of the program is to enhance shareholder value and to stabilize stock price. The program will expire on June 15, 2020. As of March 12, 2020, the company had no shares in treasury within scope available for dividend and had 1,313 shares in treasury through other repurchase.
Choong Ang Vaccine Laboratory Co., Ltd. is a Korea-based company mainly engaged in the manufacturing and marketing of veterinary vaccines. The Company provides veterinary vaccines for fowl, dogs, pigs, cattle, rabbits, cats, fishes and others under the brand name SuiShot, PoulShot, Canishot, BoviShot, FeliShot, RabbiShot and AquaShot. The Company also provides diagnosis services, and distributes other veterinary drugs, such as antibiotics, anthelmintics, disinfectants and feed additives. The Company distributes its products within domestic market and to overseas markets.
CHOONG ANG VACCINE LABORATORY CO., LTD. 
